See more : Holly Energy Partners, L.P. (HEP) Income Statement Analysis – Financial Results
Complete financial analysis of CME Group Inc. (CME) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CME Group Inc., a leading company in the Financial – Data & Stock Exchanges industry within the Financial Services sector.
You may be interested
- Tata Coffee Limited (TATACOFFEE.NS) Income Statement Analysis – Financial Results
- Nevada Exploration Inc. (NVDEF) Income Statement Analysis – Financial Results
- Affinor Growers Inc. (RSSFF) Income Statement Analysis – Financial Results
- INVO Bioscience, Inc. (INVO) Income Statement Analysis – Financial Results
- Tayih Kenmos Auto parts Co., Ltd. (8107.TWO) Income Statement Analysis – Financial Results
CME Group Inc. (CME)
Industry: Financial - Data & Stock Exchanges
Sector: Financial Services
Website: https://www.cmegroup.com
About CME Group Inc.
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.58B | 5.02B | 4.69B | 4.88B | 4.87B | 4.31B | 3.64B | 3.60B | 3.33B | 3.11B | 2.94B | 2.91B | 3.28B | 3.00B | 2.61B | 2.56B | 1.76B | 1.09B | 889.77M | 721.55M | 536.04M | 469.08M | 396.63M | 226.55M |
| Cost of Revenue | 828.60M | 753.10M | 837.00M | 856.50M | 898.70M | 672.20M | 563.90M | 543.20M | 581.50M | 584.10M | 554.20M | 536.80M | 518.00M | 472.70M | 529.30M | 501.40M | 357.30M | 300.06M | 264.38M | 238.06M | 46.58M | 39.86M | 35.07M | 0.00 |
| Gross Profit | 4.75B | 4.27B | 3.85B | 4.03B | 3.97B | 3.64B | 3.08B | 3.05B | 2.75B | 2.53B | 2.38B | 2.38B | 2.76B | 2.53B | 2.08B | 2.06B | 1.40B | 789.89M | 625.39M | 483.49M | 489.46M | 429.22M | 361.56M | 0.00 |
| Gross Profit Ratio | 85.15% | 85.00% | 82.15% | 82.46% | 81.54% | 84.40% | 83.90% | 84.21% | 82.52% | 81.23% | 81.13% | 81.58% | 78.78% | 78.67% | 79.74% | 83.23% | 79.65% | 72.47% | 93.05% | 93.17% | 91.31% | 91.50% | 91.16% | 100.00% |
| Research & Development | 218.70M | 188.60M | 192.60M | 198.50M | 201.50M | 117.20M | 101.60M | 97.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 144.40M | 137.40M | 151.70M | 191.30M | 174.10M | 453.90M | 421.40M | 437.70M | 403.60M | 398.20M | 360.10M | 337.10M | 162.40M | 157.50M | 165.50M | 71.94M | 137.00M | 79.51M | 279.34M | 261.28M | 230.32M | 204.34M | 200.08M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 141.65M | 0.00 | 16.74M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.22M |
| SG&A | 144.40M | 137.40M | 151.70M | 191.30M | 174.10M | 453.90M | 421.40M | 437.70M | 403.60M | 398.20M | 360.10M | 337.10M | 162.40M | 157.50M | 165.50M | 213.59M | 137.00M | 96.25M | 279.34M | 261.28M | 230.32M | 204.34M | 200.08M | 5.22M |
| Other Expenses | 1.17B | 1.11B | 1.06B | 1.20B | 1.21B | 575.70M | 324.50M | 387.00M | 353.00M | 361.80M | 385.00M | 348.70M | 260.50M | 375.00M | 323.60M | 544.48M | 185.26M | 72.78M | 64.92M | 53.41M | 53.02M | 48.51M | 37.64M | 229.42M |
| Operating Expenses | 1.31B | 1.25B | 1.21B | 1.39B | 1.38B | 1.03B | 745.90M | 824.70M | 756.60M | 760.00M | 745.10M | 685.80M | 422.90M | 532.50M | 489.10M | 544.48M | 322.25M | 169.03M | 344.25M | 314.69M | 283.33M | 252.85M | 237.72M | 234.64M |
| Cost & Expenses | 2.14B | 2.00B | 2.04B | 2.25B | 2.28B | 1.70B | 1.33B | 1.39B | 1.34B | 1.34B | 1.30B | 1.22B | 1.12B | 1.17B | 1.02B | 973.99M | 679.55M | 469.09M | 412.14M | 366.13M | 329.92M | 292.71M | 272.79M | 234.64M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.80M | 38.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 159.40M | 162.70M | 166.90M | 166.20M | 178.00M | 157.70M | 117.00M | 123.50M | 117.40M | 119.40M | 151.40M | 132.20M | 116.90M | 140.30M | 134.00M | 108.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 352.60M | 2.00B | 2.04B | 2.25B | 2.28B | 1.76B | 1.33B | 1.49B | 129.20M | 132.60M | 135.10M | 136.90M | 128.50M | 129.90M | 126.30M | 137.34M | 105.65M | 72.78M | 68.22M | 56.93M | 53.02M | 48.51M | 37.64M | 33.49M |
| EBITDA | 3.79B | 3.37B | 2.99B | 3.14B | 3.13B | 2.93B | 2.51B | 2.45B | 2.23B | 2.02B | 1.89B | 1.95B | 2.15B | 1.96B | 1.72B | 1.72B | 1.16B | 693.64M | 565.16M | 386.67M | 206.13M | 176.37M | 161.48M | 25.41M |
| EBITDA Ratio | 67.90% | 62.77% | 59.56% | 57.14% | 56.42% | 63.26% | 66.53% | 64.86% | 63.66% | 61.08% | 60.35% | 62.75% | 65.52% | 65.29% | 65.65% | 67.14% | 65.84% | 63.64% | 57.83% | 51.36% | 38.45% | 37.60% | 31.22% | 11.21% |
| Operating Income | 3.44B | 3.02B | 2.65B | 2.64B | 2.59B | 2.61B | 2.31B | 2.20B | 1.99B | 1.77B | 1.64B | 1.69B | 2.02B | 1.83B | 1.59B | 1.58B | 1.05B | 620.86M | 565.16M | 386.67M | 206.13M | 176.37M | 123.84M | -8.08M |
| Operating Income Ratio | 61.58% | 60.08% | 56.40% | 54.01% | 53.16% | 60.51% | 63.43% | 61.27% | 59.78% | 56.82% | 55.75% | 58.05% | 61.61% | 60.96% | 60.82% | 61.78% | 59.82% | 56.96% | 57.83% | 51.36% | 38.45% | 37.60% | 31.22% | -3.57% |
| Total Other Income/Expenses | 717.90M | 474.40M | 728.40M | 84.70M | 101.80M | 170.20M | 215.70M | 87.10M | -31.90M | 3.00M | -36.00M | 1.40M | -84.60M | -109.20M | -151.60M | -334.23M | 45.31M | 50.80M | 87.57M | -19.01M | 0.00 | -22.14M | -9.48M | 0.00 |
| Income Before Tax | 4.15B | 3.49B | 3.37B | 2.72B | 2.69B | 2.78B | 2.53B | 2.29B | 1.96B | 1.77B | 1.60B | 1.69B | 1.94B | 1.72B | 1.44B | 1.25B | 1.10B | 671.66M | 508.38M | 367.66M | 206.13M | 154.23M | 114.37M | -8.08M |
| Income Before Tax Ratio | 74.45% | 69.54% | 71.94% | 55.74% | 55.25% | 64.46% | 69.31% | 63.63% | 58.82% | 56.91% | 54.52% | 58.10% | 59.03% | 57.33% | 55.02% | 48.73% | 62.40% | 61.62% | 52.02% | 48.84% | 38.45% | 32.88% | 28.83% | -3.57% |
| Income Tax Expense | 927.40M | 799.30M | 736.70M | 615.70M | 573.80M | 814.10M | -1.54B | 753.50M | 709.80M | 644.50M | 622.90M | 786.70M | 122.10M | 769.80M | 611.70M | 532.48M | 437.27M | 264.31M | 201.52M | 148.10M | 83.99M | 60.16M | 46.06M | -3.34M |
| Net Income | 3.23B | 2.69B | 2.64B | 2.11B | 2.12B | 1.96B | 4.06B | 1.53B | 1.25B | 1.13B | 976.80M | 896.30M | 1.81B | 951.40M | 825.80M | 715.49M | 658.53M | 407.35M | 306.86M | 219.56M | 122.13M | 94.07M | 68.30M | -5.91M |
| Net Income Ratio | 57.83% | 53.61% | 56.22% | 43.11% | 43.48% | 45.53% | 111.49% | 42.67% | 37.48% | 36.21% | 33.27% | 30.75% | 55.24% | 31.67% | 31.61% | 27.94% | 37.50% | 37.37% | 31.40% | 29.17% | 22.78% | 20.05% | 17.22% | -2.61% |
| EPS | 8.87 | 7.41 | 7.30 | 5.88 | 5.93 | 5.73 | 12.00 | 4.55 | 3.71 | 3.37 | 2.94 | 2.71 | 5.45 | 2.87 | 2.49 | 2.44 | 3.01 | 2.35 | 1.79 | 1.31 | 0.75 | 0.65 | 0.47 | -0.04 |
| EPS Diluted | 8.86 | 7.40 | 7.29 | 5.87 | 5.91 | 5.71 | 11.94 | 4.53 | 3.69 | 3.35 | 2.92 | 2.70 | 5.43 | 2.86 | 2.48 | 2.43 | 2.99 | 2.32 | 1.76 | 1.28 | 0.72 | 0.63 | 0.47 | -0.04 |
| Weighted Avg Shares Out | 359.02M | 358.71M | 358.34M | 357.76M | 357.16M | 342.34M | 338.71M | 337.50M | 336.22M | 334.41M | 332.68M | 331.25M | 332.74M | 331.50M | 331.83M | 293.69M | 218.77M | 173.48M | 171.58M | 167.72M | 163.46M | 145.33M | 143.87M | 143.87M |
| Weighted Avg Shares Out (Dil) | 359.50M | 359.18M | 358.93M | 358.52M | 358.24M | 343.74M | 340.23M | 338.97M | 337.89M | 336.06M | 334.40M | 332.32M | 333.81M | 332.48M | 332.74M | 294.84M | 220.54M | 175.62M | 174.20M | 172.05M | 169.67M | 150.30M | 146.37M | 143.87M |
Can CME Group Retain its Beat Streak This Earnings Season?
A diverse product portfolio, increased volatility and a strong market position are likely to have aided CME's performance in the third quarter.
Bitcoin on Track to Hit $70,000: 4 Crypto-Centric Stocks With Upside
Bitcoin-centric stocks like NVDA, CME, IBKR and ACN are poised to gain from the ongoing cryptocurrency rally.
Wakeup Call - It's Time To Buy High-Yield Dividends
The market is experiencing robust earnings growth, low inflation, and solid GDP figures, leading many to feel bullish despite underlying economic challenges. While valuations are high, investors are banking on an "immaculate soft landing" for growth, making high-quality dividend stocks...
Countdown to CME (CME) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Evaluate the expected performance of CME (CME) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
CME Group Announces First Trades of CBL Australian Carbon Credit Unit (ACCU) Futures
CHICAGO , Oct. 17, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced its new CBL Australian Carbon Credit Unit (ACCU) futures have launched and are available for trading. A total of five contracts traded as a...
3 Bitcoin-Related Stocks to Gain From Crypto Rally
Bitcoin-centric stocks like Robinhood Markets (HOOD), NVIDIA (NVDA) and CME Group (CME) are poised to benefit from the ongoing rally.
CME Group (CME) Earnings Expected to Grow: Should You Buy?
CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pockets Of Value On The Long Side Despite Markets Sitting Near All-Time Highs
Added new longs: CME Group, CompoSecure, and Mitsubishi Heavy Industries during early August market dip; exited Finning and reduced Garmin and Kongsberg due to full valuations. CME Group is undervalued with strong potential due to its monopoly-like position in derivatives...
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
CME Group International Average Daily Volume Reached New Record of 8.4 Million Contracts in Q3 2024
Record Europe, Middle East and Africa (EMEA) ADV of 6.2M, up 30% in Q3 2024 Asia Pacific (APAC) ADV of 1.8M, up 28% LONDON and SINGAPORE , Oct. 14, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today...
Source: https://incomestatements.info
Category: Stock Reports